LAYLA ABUSHAMAT to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications LAYLA ABUSHAMAT has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
1.524
-
LDL-C Lowering in Prevention of Atherosclerotic Cardiovascular Disease: Another Step Forward in This Lifelong Marathon. J Am Coll Cardiol. 2024 02 13; 83(6):665-668.
Score: 0.537
-
Lipid-Lowering Therapy in the Elderly: Are Current Guidelines a Sign of Ageism in Medical Care? J Am Coll Cardiol. 2023 04 11; 81(14):1350-1352.
Score: 0.506
-
Lowering LDL cholesterol in clinical practice: time for change? Lancet. 2022 07 30; 400(10349):341-343.
Score: 0.481